Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy

Survey of Ophthalmology

Volumn 43, Issue 6 SUPPL., 1999, Pages

  Levin, Leonard A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; Glaucomatous optic; Neuropathy; Neuroprotection

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CERULOPLASMIN; CILIARY NEUROTROPHIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIN; SCAVENGER;

APOPTOSIS; CELL SURVIVAL; CONFERENCE PAPER; GENE TARGETING; GLAUCOMA; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; NERVE CELL NECROSIS; NEUROPROTECTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA GANGLION CELL; TRANSCRIPTION REGULATION;

APOPTOSIS; GENE THERAPY; GLAUCOMA; HUMANS; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 0032769075     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(99)00027-2     Document Type: Conference Paper

References (26)

1. Bingle C.D., Fleming R.E., Gitlin J.D. Interaction of CCAAT/enhancer-binding protein alpha and beta with the rat caeruloplasmin gene promoter. Biochem J. 294:1993;473-479.
2. Cellerino A., Kohler K. Brain-derived neurotrophic factor/neurotrophin-4 receptor TrkB is localized on ganglion cells and dopaminergic amacrine cells in the vertebrate retina. J Comp Neurol. 386:1997;149-160.
3. Di Polo A., Aigner L.J., Dunn R.J.et al. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci USA. 95:1998;3978-3983.
4. Dreyer E.B. A proposed role for excitotoxicity in glaucoma. J Glaucoma. 7:1998;62-67.
5. Fleming R.E., Gitlin J.D. Structural and functional analysis of the 5′-flanking region of the rat ceruloplasmin gene. J Biol Chem. 267:1992;479-486.
6. Furukawa K., Estus S., Fu W.et al. Neuroprotective action of cyclohexirnide involves induction of bcl-2 and antioxidant pathways. J Cell Biol. 136:1997;1137-1149.
7. Group A.C.T.S. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliaryneurotrophic factor (RHCNTF) in amyotrophic lateral sclerosis. Neurology. 46:1996;1244-1249.
8. Hall E.D., Braughler J.M. Free radicals in CNS injury. Res Publ Assoc Res Nerv Ment Dis. 71:1993;81-105.
9. Hall ED, Braughler JM, McCall JM: Antioxidant effects in brain and spinal cord injury. J Neurotrauma 1: 1992.
10. Herzog K.H., von Bartheld C.S. Contributions of the optic tectum and the retina as sources of brain-derived neurotrophic factor for retinal ganglion cells in the chick embryo. J Neurosci. 18:1998;2891-2906.
11. Kaiser P.K., Lipton S.A. VIP-mediated increase in CAMP prevents tetrodotoxin-induced retinal ganglion cell death in vitro. Neuron. 5:1990;373-381.
12. Kobayashi T., Nakamura H., Yasuda M. Disturbance of refinement of retinotectal projection in chick embryos by tetrodotoxin and grayanotoxin. Dev Brain Res. 57:1990;29-35.
13. Koistinaho J, Hokfelt T: Altered gene expression in brain ischemia. Neuroreport 8:i-viii, 1997.
14. Levin L.A. Mechanisms of optic neuropathy. Curr Opin Ophthalmol. 8:1997;9-15.
15. Levin L.A., Geszvain K.M. Expression of ceruloplasmin in the retina. Induction after retinal ganglion cell axotomy Invest Ophthalmol Vis Sci. 39:1998;157-163.
16. Levin L.A., Schlamp C.L., Spieldoch R.L.et al. Identification of the bcl-2 family genes in the rat retina. Invest Ophthalmol Vis Sci. 38:1997;2545-2553.
17. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 330:1994;613-622.
18. Meyer-Franke A., Kaplan M.R., Pfrieger F.W., Barres B.A. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron. 15:1995;805-819.
19. Minckler D.S., Bunt A.H., Johanson G.W. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci. 16:1977;426-441.
20. Perez M.T., Caminos E. Expression of brain-derived neurotrophic factor and of its functional receptor in neonatal and adult rat retina. Neurosci Lett. 183:1995;96-99.
21. Rajan P., Stewart C.L., Fink J.S. LIF-mediated activation of STAT proteins after neuronal injury in vivo. Neuroreport. 6:1995;2240-2244.
22. Scheetz A.J., Williams R.W., Dubin M.W. Severity of ganglion cell death during early postnatal development is modulated by both neuronal activity and binocular competition. Vis Neurosci. 12:1995;605-610.
23. Tanelian D.L., Barry M.A., Johnston S.A.et al. Controlled gene gun delivery and expression of DNA within the cornea. Biotechniques. 23:1997;484-488.
24. Yao G.L., Kato H., Khalil M.et al. Selective upregulation of cytokine receptor subchain and their intracellular signalling molecules after peripheral nerve injury. Eur J Neurosci. 9:1997;1047-1054.
25. Yoles E., Muller S., Schwartz M. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J Neurotrauma. 14:1997;665-675.
26. Yoles E., Schwartz M. Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol. 42:1998;367-372.